209 related articles for article (PubMed ID: 28885458)
1. Compassionate Nitric Oxide Adjuvant Treatment of Persistent Mycobacterium Infection in Cystic Fibrosis Patients.
Yaacoby-Bianu K; Gur M; Toukan Y; Nir V; Hakim F; Geffen Y; Bentur L
Pediatr Infect Dis J; 2018 Apr; 37(4):336-338. PubMed ID: 28885458
[TBL] [Abstract][Full Text] [Related]
2. Pilot study to test inhaled nitric oxide in cystic fibrosis patients with refractory Mycobacterium abscessus lung infection.
Bentur L; Gur M; Ashkenazi M; Livnat-Levanon G; Mizrahi M; Tal A; Ghaffari A; Geffen Y; Aviram M; Efrati O
J Cyst Fibros; 2020 Mar; 19(2):225-231. PubMed ID: 31129068
[TBL] [Abstract][Full Text] [Related]
3. Outcomes associated with antibiotic regimens for treatment of Mycobacterium abscessus in cystic fibrosis patients.
DaCosta A; Jordan CL; Giddings O; Lin FC; Gilligan P; Esther CR
J Cyst Fibros; 2017 Jul; 16(4):483-487. PubMed ID: 28495380
[TBL] [Abstract][Full Text] [Related]
4. Improved Clinical Outcome After Treatment of Mycobacterium abscessus Complex Pulmonary Disease in Children With Cystic Fibrosis.
Chacko A; Wen SCH; Hartel G; Kapur N; Wainwright CE; Clark JE
Pediatr Infect Dis J; 2019 Jul; 38(7):660-666. PubMed ID: 30724835
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of pulmonary
Flight WG; Hough NE; Chapman SJ
Int J Mycobacteriol; 2020; 9(1):48-52. PubMed ID: 32474488
[TBL] [Abstract][Full Text] [Related]
6. Combined Host- and Pathogen-Directed Therapy for the Control of Mycobacterium abscessus Infection.
Poerio N; Riva C; Olimpieri T; Rossi M; Lorè NI; De Santis F; Henrici De Angelis L; Ciciriello F; D'Andrea MM; Lucidi V; Cirillo DM; Fraziano M
Microbiol Spectr; 2022 Feb; 10(1):e0254621. PubMed ID: 35080463
[TBL] [Abstract][Full Text] [Related]
7. Radiologic computed tomography features of Mycobacterium abscessus in cystic fibrosis.
Lam DL; Kapnadak SG; Godwin JD; Kicska GA; Aitken ML; Pipavath SN
Clin Respir J; 2018 Feb; 12(2):459-466. PubMed ID: 27460837
[TBL] [Abstract][Full Text] [Related]
8. Antimycobacterial activity of nonantibiotics associated with the polypharmacy of cystic fibrosis (CF) against mycobacterium abscessus.
Kirkwood ZI; Millar BC; Downey DG; Moore JE
Int J Mycobacteriol; 2018; 7(4):358-360. PubMed ID: 30531035
[TBL] [Abstract][Full Text] [Related]
9. Mycobacterium abscessus Cells Have Altered Antibiotic Tolerance and Surface Glycolipids in Artificial Cystic Fibrosis Sputum Medium.
Hunt-Serracin AC; Parks BJ; Boll J; Boutte CC
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010859
[No Abstract] [Full Text] [Related]
10. Antimycobacterial activity of veterinary antibiotics (Apramycin and Framycetin) against
Moore JE; Koulianos G; Hardy M; Misawa N; Millar BC
Int J Mycobacteriol; 2018; 7(3):265-267. PubMed ID: 30198508
[TBL] [Abstract][Full Text] [Related]
11. Interaction of South Asian spices with conventional antibiotics: Implications for antimicrobial resistance for
Moore RE; Millar BC; Panickar JR; Moore JE
Int J Mycobacteriol; 2018; 7(3):257-260. PubMed ID: 30198506
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial properties of basidiomycota macrofungi to
Millar BC; Nelson D; Moore RE; Rao JR; Moore JE
Int J Mycobacteriol; 2019; 8(1):93-97. PubMed ID: 30860186
[TBL] [Abstract][Full Text] [Related]
13. Children With Cystic Fibrosis Are Infected With Multiple Subpopulations of Mycobacterium abscessus With Different Antimicrobial Resistance Profiles.
Shaw LP; Doyle RM; Kavaliunaite E; Spencer H; Balloux F; Dixon G; Harris KA
Clin Infect Dis; 2019 Oct; 69(10):1678-1686. PubMed ID: 30689761
[TBL] [Abstract][Full Text] [Related]
14. Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis.
Howlin RP; Cathie K; Hall-Stoodley L; Cornelius V; Duignan C; Allan RN; Fernandez BO; Barraud N; Bruce KD; Jefferies J; Kelso M; Kjelleberg S; Rice SA; Rogers GB; Pink S; Smith C; Sukhtankar PS; Salib R; Legg J; Carroll M; Daniels T; Feelisch M; Stoodley P; Clarke SC; Connett G; Faust SN; Webb JS
Mol Ther; 2017 Sep; 25(9):2104-2116. PubMed ID: 28750737
[TBL] [Abstract][Full Text] [Related]
15. Non-tuberculous mycobacteria infection treated with intermittently inhaled high-dose nitric oxide.
Goldbart A; Gatt D; Golan Tripto I
BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34711619
[No Abstract] [Full Text] [Related]
16. Rapid detection and immune characterization of Mycobacterium abscessus infection in cystic fibrosis patients.
Steindor M; Nkwouano V; Mayatepek E; Mackenzie CR; Schramm D; Jacobsen M
PLoS One; 2015; 10(3):e0119737. PubMed ID: 25742660
[TBL] [Abstract][Full Text] [Related]
17.
Tippett E; Ellis S; Wilson J; Kotsimbos T; Spelman D
Int J Mycobacteriol; 2018; 7(2):109-116. PubMed ID: 29900884
[TBL] [Abstract][Full Text] [Related]
18. The importance of early diagnosis of Mycobacterium abscessus complex in patients with cystic fibrosis.
Ravnholt C; Kolpen M; Skov M; Moser C; Katzenstein TL; Pressler T; Høiby N; Qvist T
APMIS; 2018 Dec; 126(12):885-891. PubMed ID: 30456869
[TBL] [Abstract][Full Text] [Related]
19. Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients.
Roux AL; Catherinot E; Soismier N; Heym B; Bellis G; Lemonnier L; Chiron R; Fauroux B; Le Bourgeois M; Munck A; Pin I; Sermet I; Gutierrez C; Véziris N; Jarlier V; Cambau E; Herrmann JL; Guillemot D; Gaillard JL;
J Cyst Fibros; 2015 Jan; 14(1):63-9. PubMed ID: 25085077
[TBL] [Abstract][Full Text] [Related]
20. Successful lung transplantation for chronic Mycobacterium abscessus infection in advanced cystic fibrosis, a case series.
Raats D; Lorent N; Saegeman V; Vos R; van Ingen J; Verleden G; Van Raemdonck D; Dupont L
Transpl Infect Dis; 2019 Apr; 21(2):e13046. PubMed ID: 30597699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
